Cutaneous T-cell lymphoma (CTCL) is a type of non-Hodgkin lymphoma characterized by the proliferation of malignant T-cells in the skin. When classified as unspecified with involvement of intra-abdominal lymph nodes, it indicates a more advanced stage of the disease. Accurate coding with ICD-10 Code C84.A3 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this complex condition effectively.
ICD-10 Code C84.A3 represents Cutaneous T-cell lymphoma, unspecified, with involvement of intra-abdominal lymph nodes. This code is used when a patient presents with CTCL that has progressed to include lymph nodes in the abdominal region. It is crucial for clinical documentation and billing to accurately reflect the patient's condition and ensure appropriate treatment and resource allocation.
Cutaneous T-cell lymphoma is a rare form of cancer that originates in T-cells and primarily affects the skin. The unspecified designation indicates a lack of specific subtype classification, while the involvement of intra-abdominal lymph nodes suggests a more advanced disease state that necessitates prompt medical intervention.
ICD-10 Code C84.A3 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring that healthcare providers can effectively communicate the patient's condition and treatment needs.
In SOAP notes, ICD-10 Code C84.A3 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutaneous T-cell lymphoma with intra-abdominal lymph node involvement. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Cutaneous T-cell lymphoma with intra-abdominal lymph node involvement requires a multidisciplinary approach, often necessitating hospitalization for advanced treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.A3 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 96415 | Chemotherapy administration, intravenous, infusion technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with automated differential white blood cell count. |
Common Questions About Using ICD-10 Code C84.A3 for Cutaneous T-cell lymphoma, unsp, intra-abdominal lymph nodes
What are the common symptoms of Cutaneous T-cell lymphoma?
Common symptoms include itchy or scaly skin lesions, lymphadenopathy, and systemic symptoms such as fever and weight loss. Patients may also experience abdominal discomfort if intra-abdominal lymph nodes are involved.
How is Cutaneous T-cell lymphoma diagnosed?
Diagnosis typically involves a skin biopsy to confirm the presence of malignant T-cells, along with imaging studies to assess lymph node involvement and disease progression.
What treatment options are available for this condition?
Treatment may include topical therapies, phototherapy, systemic chemotherapy, or immunotherapy, depending on the stage and severity of the disease.
Is Cutaneous T-cell lymphoma contagious?
No, Cutaneous T-cell lymphoma is not contagious. It is a type of cancer that arises from the body's immune cells and cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes